AR and prostate cancer: Progression of AR-dependent adenocarcinoma through lineage plasticity to AR-independent forms of prostate cancer, such as double-negative prostate cancer (DNPC) — lacking both AR expression and NEPC differentiation — or NEPC through lineage plasticity, is now increasingly recognized (5, 11, 12, 24, 47, 48).